[Postpartal lactation inhibition by 2-Br-alpha-ergocryptine: I. A comparative study with 2-Br-alpha-ergocryptine in different dosages and placebo (author's transl)].
D001794:Blood Pressure; D001966:Bromine / Q000008:administration & dosage / Q000494:pharmacology; D002986:Clinical Trials as Topic; D004876:Ergot Alkaloids / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D006801:Humans; D007774:Lactation / Q000187:drug effects*; D010919:Placebos; D011247:Pregnancy; D011674:Pulse; D013997:Time Factors
D004876:Ergot Alkaloids; D010919:Placebos; D001966:Bromine
Postpartale Laktationshemmung durch 2-Br-Alpha-Ergokryptin: I. Eine Vergleichsuntersuchung mit 2-Br-Alpha-Ergokryptin in unterschiedlicher Dosierung und Plazebo